Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer

Tumors frequently express unmutated self-tumor–associated antigens (self-TAAs). However, trial results using self-TAAs as vaccine targets against cancer are mixed, often attributed to deletion of T cells with high-affinity receptors (TCRs) for self-TAAs during T cell development. Mutating these weak...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Proc Natl Acad Sci U S A
المؤلفون الرئيسيون: Wei, Pengcheng, Jordan, Kimberly R., Buhrman, Jonathan D., Lei, Jun, Deng, Hexiang, Marrack, Philippa, Dai, Shaodong, Kappler, John W., Slansky, Jill E., Yin, Lei
التنسيق: Artigo
اللغة:Inglês
منشور في: National Academy of Sciences 2021
الموضوعات:
Biological Sciences
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC8201969/
https://ncbi.nlm.nih.gov/pubmed/34074778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.2100588118
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة